NCT07123714

Brief Summary

This randomized controlled double blinded study will be carried out on 140 patients underwent elective fit laparoscopic cholecystectomy at El-Rajhi Assiut University Hospital. Inclusion criteria:

  • 20-50 years old.
  • Both sexes.
  • American society of anesthesiologists (ASA) physical status I-II.
  • Elective fit laparoscopic cholecystectomy Exclusion criteria:
  • Patient refusal.
  • Patients with history of hypersensitivity to magnesium sulfate.
  • Patients with coronary ischemic disease, atrioventricular block of any degree, known cardiac arrhythmias, heart failure on beta blockers or calcium channel blockers expected difficult intubation (Mallampati 4).
  • Body mass index (BMI) \> 40 kg/m2. An online randomization program (http://www.randomizer.org) will be used to generate a random list and each patients' code will be kept in an opaque sealed envelope. Patients will be randomly allocated with 1:1 allocation ratio into two equal groups in a parallel manner:
  • Group A: (N=70) Patients will receive nebulized magnesium sulfate in 5 ml (250 mg) over 15 min.
  • Group B: (N=70) Patients received nebulized normal saline in 5 ml over 15 min, ending 5 min before the induction of anesthesia. A. Preoperative assessment: All patients will be subjected to the followings:
  • Demographic data collection (age, weight, height, BMI, and ASA).
  • Complete clinical examination.
  • Routine Laboratory investigations:
  • Random blood sugar.
  • Blood sample withdrawal for cortisol level at baseline 2ml intravenously. The sample will be sent to be centrifugated within 30 minutes and the serum will be separated and stored in -20°C till time of cortisol level by ELIZA technique.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
140

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2025

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 8, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 14, 2025

Completed
6 days until next milestone

Study Start

First participant enrolled

August 20, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2025

Completed
9 days until next milestone

Study Completion

Last participant's last visit for all outcomes

November 10, 2025

Completed
Last Updated

August 14, 2025

Status Verified

August 1, 2025

Enrollment Period

2 months

First QC Date

August 8, 2025

Last Update Submit

August 8, 2025

Conditions

Keywords

Magnesium sulfate nebulizationpostoperative sore throatPost-intubation sore throatPost-intubation stress response

Outcome Measures

Primary Outcomes (1)

  • Difference between preoperative cortisol level and 6minutes after intubation

    cortisol level will be measured preoperatively and 6 minutes after intubation then calculation of the difference between them then comparison between both groups

    6 minutes after intubation

Secondary Outcomes (3)

  • NRS for sore throat postoperatively

    24 hours

  • 4 grade scale

    24 hours postoperatively

  • Random blood sugar RBS

    6 minutes after intubation

Study Arms (2)

Nebulized magnesium sulfate group

EXPERIMENTAL

Patients will receive nebulized magnesium sulfate in 5 ml (250 mg) over 15 min.

Procedure: Nebulization of magnesium sulfate

control group

NO INTERVENTION

Patients will receive nebulized normal saline 5ml, 15 minutes preoperatively

Interventions

patient will be nebulized with 5 mg magnesium sulfate (5 ml) 15 minutes before induction of anesthesia

Nebulized magnesium sulfate group

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • American society of anesthesiologists (ASA) physical status I-II.
  • Elective fit laparoscopic cholecystectomy

You may not qualify if:

  • Patient refusal.
  • Patients with history of hypersensitivity to magnesium sulphate.
  • Patients with coronary ischemic disease, atrioventricular block of any degree, known cardiac arrhythmias, heart failure on beta blockers or calcium channel blockers expected difficult intubation (Mallampati 4).
  • Body mass index (BMI) \> 40 kg/m2.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (3)

  • Yadav M, Chalumuru N, Gopinath R. Effect of magnesium sulfate nebulization on the incidence of postoperative sore throat. J Anaesthesiol Clin Pharmacol. 2016 Apr-Jun;32(2):168-71. doi: 10.4103/0970-9185.173367.

    PMID: 27275043BACKGROUND
  • 2. Gutiérrez-Román, C.I., O. Carrillo-Torres and E.S. Pérez-Meléndez, Uses of magnesium sulfate in anesthesiology. Revista médica del Hospital General de México, 2022. 85(1): p. 25-33, .

    BACKGROUND
  • Chen Z, Zuo Z, Zhang L, Gong M, Ye Y, Jin Y, Zhao X. Postoperative Sore Throat After Tracheal Intubation: An Updated Narrative Review and Call for Action. J Pain Res. 2025 May 6;18:2285-2306. doi: 10.2147/JPR.S498933. eCollection 2025.

    PMID: 40352818BACKGROUND

MeSH Terms

Conditions

Pharyngitis

Condition Hierarchy (Ancestors)

Respiratory Tract InfectionsInfectionsPharyngeal DiseasesStomatognathic DiseasesRespiratory Tract DiseasesOtorhinolaryngologic Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer

Study Record Dates

First Submitted

August 8, 2025

First Posted

August 14, 2025

Study Start

August 20, 2025

Primary Completion

November 1, 2025

Study Completion

November 10, 2025

Last Updated

August 14, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will share